Rigel Pharmaceuticals Inc. (RIGL) is Trading Higher on Unusual Volume for January 22

Equities Staff |

Rigel Pharmaceuticals Inc. (RIGL) experienced unusually high volume on Jan. 22, as the stock gained 0.74% to a closing price of $2.74. The stock saw 1.52 million shares trade hands over the course of the day on 3,366 trades. Given that the stock’s average daily volume over the last month has been 651,556 shares a day, this represents a pretty substantial spike over the norm.

Rigel Pharmaceuticals Inc. has a P/B ratio of 2.51. The stock has traded between $5.20 and $2.03 over the last 52-weeks, its 50-day SMA is now $3.11, and its 200-day SMA $3.24.

Rigel Pharmaceuticals Inc is a clinical-stage drug development company. It discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.

Headquartered in South San Francisco, CA, Rigel Pharmaceuticals Inc. has 127 employees and is currently under the leadership of CEO Raul R. Rodriguez.

For a complete fundamental analysis analysis of Rigel Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for RIGL. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

THE IMPORTANCE OF THE RUSSELL 3000

The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…